Compare THRY & SEER Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | THRY | SEER |
|---|---|---|
| Founded | 2012 | 2017 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Medicinal Chemicals and Botanical Products |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 114.8M | 97.3M |
| IPO Year | 2020 | 2020 |
| Metric | THRY | SEER |
|---|---|---|
| Price | $3.43 | $1.79 |
| Analyst Decision | Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $9.33 | N/A |
| AVG Volume (30 Days) | ★ 949.3K | 406.3K |
| Earning Date | 04-30-2026 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 100.50 | 9.40 |
| EPS | ★ 0.10 | N/A |
| Revenue | ★ $785,015,000.00 | $16,578,000.00 |
| Revenue This Year | N/A | $2.14 |
| Revenue Next Year | N/A | $25.90 |
| P/E Ratio | $34.60 | ★ N/A |
| Revenue Growth | N/A | ★ 16.99 |
| 52 Week Low | $1.91 | $1.65 |
| 52 Week High | $14.47 | $2.41 |
| Indicator | THRY | SEER |
|---|---|---|
| Relative Strength Index (RSI) | 49.34 | 41.53 |
| Support Level | $3.09 | $1.71 |
| Resistance Level | $3.69 | $1.84 |
| Average True Range (ATR) | 0.34 | 0.08 |
| MACD | -0.04 | -0.02 |
| Stochastic Oscillator | 26.52 | 0.00 |
Thryv Holdings Inc is dedicated to supporting local, independent service-based businesses and emerging franchises by providing a cloud-based software platform, and marketing solutions to entrepreneurs. The group are provider of SaaS all-in-one small business management software in addition to providing print and digital marketing solutions to SMBs. Its solutions enable small and medium-sized business clients to attract and generate new business leads, manage their customer relationships efficiently with artificial intelligence (AI) tools and automation. The group has two business segments; Thryv SaaS deriving maximum revenue and Thryv Marketing Services.
Seer Inc is a life sciences company, develops and commercializes products to decode the biology of the proteome. The company offers Proteograph Product Suite, an integrated solution that includes proprietary engineered nanoparticles, consumables, automation instrumentation, and data analysis software to perform proteomic analysis to provide a solution that can be incorporated by nearly any lab for research use only. It markets and sells its products for research use only, which cover academic institutions, life sciences, and research laboratories, as well as biopharmaceutical and biotechnology companies for non-diagnostic and non-clinical purposes. The company operates in China, Australia, Eastern Europe, Israel, Japan and South Africa.